Investigating how microRNA-483 affects pancreatic beta-cell function and identity
microRNA-483 regulation of pancreatic beta-cell function and identity
This study is looking at how a tiny molecule called microRNA-483 helps keep the insulin-producing cells in your pancreas healthy, and it aims to find out what happens when this molecule is missing, which could help us discover new ways to manage type 2 diabetes.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Michigan Technological University NIH-funded |
| Lab location | 1 site (Houghton, United States) |
| Project ID | NIH-10580237 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of microRNA-483 in maintaining the function and identity of pancreatic beta-cells, which are crucial for insulin production. The study aims to uncover how the loss of this microRNA leads to beta-cell dedifferentiation, a process that contributes to the progression of type 2 diabetes. By using animal models, researchers will analyze the effects of miR-483 deletion on beta-cell health and function, particularly in relation to oxidative stress and cellular viability. The findings could provide insights into new therapeutic targets for diabetes management.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with type 2 diabetes, particularly those experiencing challenges related to beta-cell function.
Not a fit: Patients with type 1 diabetes or those without any form of diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preserving beta-cell function in patients with type 2 diabetes.
How similar studies have performed: Previous research has shown that targeting microRNAs can influence cellular processes in diabetes, suggesting potential for success in this approach.
Where this research is happening
Houghton, United States
- Michigan Technological University — Houghton, United States (Active)
Researchers
- Principal investigator: Tang, Xiaoqing — Michigan Technological University
- Study coordinator: Tang, Xiaoqing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.